IBS & Gut Health
Hypnotherapy for IBS: The One Thing Hypnosis Is Named in a Guideline For
Of everything hypnosis has been tried for, irritable bowel syndrome is the only application that national clinical guidelines name by its own name. That is a real distinction and I am going to make the most of it. Then I am going to tell you exactly how far it stretches, because it does not stretch as far as the single recording I sell.
Before anything else: make sure IBS is what you have.See a doctor rather than buying a recording if you have blood in your stool or black, tarry stools; unintentional weight loss; symptoms that started after the age of 50; a family history of bowel cancer, inflammatory bowel disease or coeliac disease; anaemia or iron deficiency; symptoms that wake you from sleep; or pain that is steadily getting worse.
These are the features Australian Prescriber lists as pointing to something other than IBS. In one Dutch randomised trial, several people referred for IBS hypnotherapy turned out to have cancer or inflammatory bowel disease. Hypnosis is very safe. It cannot tell you what you have got.
Written by Ernest McLeodClinical hypnotherapist. An Adelaide practice, seeing clients across Australia by video. Fourteen years in practice. About Ernest →
I sell hypnotherapy recordings and I earn a commission when someone buys one through this site, so treat what I say about hypnotherapy accordingly. Here is what the independent evidence actually shows, including the parts that cost me the sale.
What do the guidelines actually say about hypnotherapy for IBS?
The UK’s National Institute for Health and Care Excellence names it. Clinical guideline CG61 was published in 2008, last updated in 2017, and reviewed in April 2025 without being changed, which means it still stands. Recommendation 1.2.3.1 reads, in full:
“Referral for psychological interventions (cognitive behavioural therapy [CBT], hypnotherapy or psychological therapy) should be considered for people with IBS who do not respond to pharmacological treatments after 12 months and who develop a continuing symptom profile (described as refractory IBS). [2008]”
Read the qualifiers, because they are the whole recommendation. It is second line: for people whose IBS has not responded to medication after twelve months. It is hypnotherapy or psychological therapy — a list of options, not a package. And it is dated 2008. “NICE recommends hypnotherapy for IBS”, with nothing attached, is an overclaim, and you will see it on a lot of pages selling this.
The British Society of Gastroenterology goes further, in its 2021 guideline in Gut: “Gut-directed hypnotherapy may be an efficacious treatment for global symptoms in IBS (recommendation: strong, quality of evidence: low).” Both halves of that sentence matter. BSG also liberalises the timing — it says psychological therapies should be considered after twelve months of drug treatment, but that “referral can be made at an earlier stage, if accessible locally, and based on patient preference”. And it describes gut-directed hypnotherapy as “one of the psychological therapies for IBS with the largest evidence base for both short-term and long-term efficacy in RCTs”.
The American College of Gastroenterology’s 2021 guideline is a step weaker again. Its recommendation 24 reads: “We suggest that gut-directed psychotherapies be used to treat global IBS symptoms. Conditional recommendation; very low quality of evidence.” That is a class — gut-directed CBT, hypnotherapy and mindfulness together. The ACG does not single hypnotherapy out. Worth knowing, too: one of the guideline’s behavioural-medicine authors is a cofounder and shareholder in a company commercialising a prescription gut-directed hypnotherapy app.
Australia has no equivalent. I could find no national IBS guideline or position statement from the Gastroenterological Society of Australia. The closest authoritative Australian source is Australian Prescriber, which mentions “psychologist-led cognitive behavioural therapy or hypnotherapy” only in passing. Here it is a recognised option, not a guideline-endorsed one.
How strong is the evidence underneath those recommendations?
Weaker than the endorsements make it sound, and every one of those guideline panels says so itself. NICE’s recommendation dates from 2008. The BSG rates its evidence low. The ACG rates its evidence very low. A strong recommendation built on low-quality evidence is a legitimate thing for a guideline to issue — it means the panel thinks the balance of benefit and harm is clear even though the trials are small and imperfect. It is not the same as a proven treatment.
The newest and largest analysis makes the point sharply. Thakur and colleagues pooled the psychological therapies for IBS in The Lancet Gastroenterology & Hepatology in 2025. Gut-directed hypnotherapy came out at a risk ratio of 0.79 (95% CI 0.66–0.95) across 12 trials and 1,507 patients — a real reduction in the chance of still having symptoms. But it also had the lowest P score of the therapies that worked, below CBT, and the certainty of evidence was rated low to very low. Hypnotherapy is in the group that helps. Within that group it ranks last.
A hypnotherapy-specific meta-analysis published the same year, by Adler and colleagues across 1,158 patients, is blunter still: all twelve included studies pointed in favour of gut-directed hypnotherapy, nine of them significantly, but when the results were pooled the effect on global IBS symptoms was not statistically significant (SMD 0.73, 95% CI −0.09 to 1.55) with extreme heterogeneity. The clearest signals were for pain, and for programmes delivered in groups or at higher session volumes. And the 2020 network meta-analysis in Gut that the BSG leaned on says, in its own words: “Risk of bias of trials was high, with evidence of funnel plot asymmetry; the efficacy of psychological therapies is therefore likely to have been overestimated.”
Where does the 70 to 80 per cent figure come from?
It is a real figure with a traceable source, and it is almost always quoted without its denominator. It comes from audits of the Manchester hospital hypnotherapy unit: 71 per cent of 204 patients in one follow-up study, 76 per cent of an audit of 1,000 patients, 81 per cent in a later series of 150. Those are people with severe, treatment-resistant IBS who self-selected into a twelve-session hospital programme and completed it, and there was no comparison group in any of them.
Put a control group next to it and the number changes. In the largest multicentre randomised trial — 354 people across eleven Dutch hospitals, in ordinary primary and secondary care rather than a tertiary clinic — six individual sessions produced adequate relief in 40.8 per cent at three months, against 16.7 per cent given educational support. Still a clear win. Not eighty per cent. In the one digital trial with a matched active control, 63 per cent of the control group hit the same improvement threshold as 81 per cent of the treated group. The controlled increment was about eighteen percentage points.
The durability figure gets the same treatment. Manchester followed 204 patients for up to six years: 71 per cent responded initially, and 81 per cent of those responders held their improvement — roughly 58 per cent of the original group, not 81 per cent of everyone, and uncontrolled. The better citation for durability is the 2014 meta-analysis, which found hypnosis superior to controls at long-term follow-up.
What was actually tested in the trials?
This is the part the marketing skips. Everything above — every guideline line, every meta-analysis, every percentage — describes a course of treatment. The BSG puts it plainly: “Traditionally, hypnotherapy for IBS has been delivered via between 6 and 12 face-to-face weekly sessions of individualised treatment with a trained therapist.” The meta-analysis of eight randomised trials found a median of 8.5 sessions over a median of 12 weeks. Sessions are tailored to your symptom pattern, and there is structured practice at home in between, often using a recording.
There is good news inside that. Six sessions turned out to be no worse than twelve in a 448-patient randomised trial funded by the UK’s National Institute for Health Research, with fewer dropouts. Group delivery held up against individual delivery, and remote video delivery works. The structure is doing the work, not the room.
Is a single recording the same as gut-directed hypnotherapy?
One recording. IBS Hypnosis, US$18.95, about A$27, an instant download from the publisher. It uses the same kind of gut-directed suggestion and imagery that those clinical programmes are built from, and you can listen as often as you like.
A single recording is not that protocol.It has not been through a trial. It is not tailored to you. It is not six to twelve weekly sessions with a therapist who adjusts it as you go. None of NICE, the BSG or the ACG has evaluated, endorsed or considered a standalone purchased audio file, and anything on the internet that puts “NICE-recommended” next to a product like mine is simply false.
What it is: one component of a studied programme, sold separately, at about one per cent of the price of the programme.
The closest thing to supporting evidence for a home recording is a small pilot: nineteen people worked through a scripted hypnosis protocol at home over three months and 53 per cent improved, against 26 per cent of a matched group on standard care. The researchers were candid that this was lower than the response rate they saw when a therapist delivered the same protocol in person. That is the ceiling of what can honestly be claimed for audio — and even that was a structured three-month course of scripted sessions, not one file.
If a structured programme is the better fit, here is what to look at
If your IBS is significantly affecting your life, a full course is the better-evidenced option, and I would rather say so than not.
A clinician. One Melbourne clinic that publishes its fees charges A$275 a session for gut-directed hypnotherapy with no Medicare rebate, which puts a six-session course near A$1,650 and a twelve-session course near A$3,300. That is one clinic’s published rate, not a national average. Where the therapy is delivered by a registered psychologist under a GP Mental Health Care Plan, a rebate may apply to the consultation; where it is delivered by a non-registered hypnotherapist, it does not.
Nerva. An Australian app from Mindset Health in Melbourne: a six-week programme of 42 daily sessions of about fifteen minutes, with flare-up tools and a maintenance plan. A$249 for full access on the Australian App Store as at 18 September 2026, with shorter subscriptions and a seven-day free trial. It has a randomised trial behind it, and a good one by design — an active control rather than a waiting list — in which 81 per cent of users met the improvement threshold against 63 per cent on the same digital programme with the hypnotherapy removed, and 71 per cent achieved a 30 per cent or greater reduction in pain against 35 per cent.
Two things you should know before that number persuades you. The trial was funded by Mindset Health, the company that sells Nerva, and one of its authors developed the app. Nerva itself states that it “has not been evaluated by the FDA, TGA, MHRA, or equivalent bodies”. Naming a competitor costs me the sale on this page. I would rather you bought the thing with the trial behind it than the thing with my commission attached.
How many people actually finish?
The single most useful number I can give you is not about efficacy. Researchers followed 2,843 people who started a smartphone gut-directed hypnotherapy programme. Half of them — 1,428 — bought it. 253 finished all 42 sessions. Outcome data existed for 190 of those, and 64 per cent of them responded. The authors’ own conclusion opens with the words “adherence to app-delivered gut-directed hypnotherapy was low”.
Whatever you buy, from me or anyone, the thing that decides whether it helps is whether you keep pressing play. A recording you listen to twice will do very little.
Get diagnosed, and get screened
IBS is a diagnosis a doctor makes, not a label you give yourself because nothing showed up. The alarm features at the top of this page should prompt further evaluation rather than a purchase. The ACG notes they have low predictive value in people with IBS — a reason for a doctor to weigh them, not a reason for you to skip one.
And separately from all of this: if you are between 45 and 74 and hold a Medicare or DVA card, the National Bowel Cancer Screening Program will send you a free test kit to do at home, repeated every two years. From 50 to 74 it arrives automatically. Between 45 and 49 you need to request your first one, through the National Cancer Screening Register or by calling 1800 627 701. Do that regardless of what you decide about hypnotherapy.
So what should you actually do?
Four situations bring almost everyone to this page, and they have four different answers. Only one of them is a recording, and it is both the cheapest and the weakest of the four. Start at the row that describes you, not at the row that happens to suit me.
| If you are… | The better-evidenced move | Why |
|---|---|---|
| Not yet diagnosed, or carrying any alarm feature | See a GP first | Bleeding, weight loss, onset after 50, family history of bowel cancer or anaemia need investigating. In one Dutch trial, people referred for IBS hypnotherapy turned out to have cancer or inflammatory bowel disease. |
| Diagnosed, and IBS is significantly affecting your life | A course with a clinician, six to twelve sessions | This is the only thing NICE, the BSG and the ACG have actually endorsed. One Melbourne clinic publishes A$275 a session, no Medicare rebate. |
| Wanting the structure without the clinic price | A structured multi-week programme such as Nerva | Six weeks, 42 daily sessions, A$249, and a randomised trial behind it — one funded by the company that sells it, with a developer among its authors. |
| Curious, low-stakes, or waiting for an appointment | The single IBS session, US$18.95 | Untested as a standalone product, not tailored to you, and not the protocol the guidelines describe. About A$27 with ninety days to change your mind. |
Common questions
Does hypnotherapy work for IBS?
It is the best-evidenced application of hypnosis, and it is named in the NICE and British Society of Gastroenterology guidelines. In the newest and largest analysis, gut-directed hypnotherapy reduced the chance of still having symptoms with a risk ratio of 0.79 across 12 trials and 1,507 patients — but it ranked last among the therapies that worked, below CBT, and the certainty of that evidence was rated low to very low.
Is hypnotherapy for IBS recommended by NICE?
Yes, with conditions. NICE clinical guideline CG61, recommendation 1.2.3.1, says referral for psychological interventions including hypnotherapy “should be considered for people with IBS who do not respond to pharmacological treatments after 12 months”. It is a second-line recommendation for refractory IBS, dated 2008, and it covers a course of therapy with a clinician — not a recording you buy.
How many sessions of gut-directed hypnotherapy do you need?
Between six and twelve weekly sessions with a trained therapist, with practice at home in between. That is what the guidelines describe and what the trials tested. A randomised trial of 448 patients found six sessions no worse than twelve, with fewer dropouts — though the authors noted there is no long-term follow-up data for the shorter course.
Do 70 to 80 per cent of people with IBS improve with hypnotherapy?
Not as that figure is usually used. It comes from uncontrolled audits of a Manchester hospital clinic treating severe, treatment-resistant IBS, counting only people who finished a full course. In the largest randomised trial, in ordinary clinical care, about 41 per cent had adequate relief after six sessions, compared with about 17 per cent given educational support.
Can a hypnosis recording replace a course of gut-directed hypnotherapy?
No, and I sell the recording. The one study that compared home-delivered scripted hypnosis with therapist delivery found the home response rate was lower — 53 per cent improved against 26 per cent on standard care, which the researchers described as below what they saw in person. A single audio file is one component of a studied programme, removed from the structure that produced the results.
Is gut-directed hypnotherapy safe?
Low risk, not zero risk. Across eight randomised trials and 238 patients receiving hypnosis, one person (0.4 per cent) dropped out because of an adverse event, a panic attack. Anxiety predicted poorer response in one home-treatment study, and the ACG notes gut-directed therapies are less effective in people with co-existing mental health conditions, who should be referred to a mental health professional.
Free and confidential, open now. Tap to call.
Where these numbers come from
- Morrison S, Talley N. Diagnosis and management of irritable bowel syndrome. Aust Prescr. 2026;49(3):93-98. doi:10.18773/austprescr.2026.018
- Flik CE, Laan W, Zuithoff NPA, et al. Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2019;4(1):20-31. doi:10.1016/S2468-1253(18)30310-8
- National Institute for Health and Care Excellence. Irritable bowel syndrome in adults: diagnosis and management. Clinical guideline [CG61]. London: NICE; 2008 [updated 2017]. nice.org.uk
- Vasant DH, Paine PA, Black CJ, et al. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut. 2021;70(7):1214-1240. doi:10.1136/gutjnl-2021-324598
- Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17-44. doi:10.14309/ajg.0000000000001036
- Thakur ER, Khasawneh M, Moayyedi P, et al. Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2025;10(12):1075-1088. doi:10.1016/S2468-1253(25)00238-9
- Adler EC, Levine EH, Ibarra AN, et al. Gut-directed hypnotherapy for irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2025;37(7):e70037. doi:10.1111/nmo.70037
- Black CJ, Thakur ER, Houghton LA, et al. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2020;69(8):1441-1451. doi:10.1136/gutjnl-2020-321191
- Gonsalkorale WM, Miller V, Afzal A, et al. Long term benefits of hypnotherapy for irritable bowel syndrome. Gut. 2003;52(11):1623-1629. doi:10.1136/gut.52.11.1623
- Miller V, Carruthers HR, Morris J, et al. Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients. Aliment Pharmacol Ther. 2015;41(9):844-855. doi:10.1111/apt.13145
- Donnet AS, Hasan SS, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions. Therap Adv Gastroenterol. 2022;15:17562848221074208. doi:10.1177/17562848221074208
- Anderson EJ, Peters SL, Gibson PR, et al. Comparison of digitally delivered gut-directed hypnotherapy program with an active control for irritable bowel syndrome. Am J Gastroenterol. 2025;120(2):440-448. doi:10.14309/ajg.0000000000002921
- Schaefert R, Klose P, Moser G, et al. Efficacy, tolerability, and safety of hypnosis in adult irritable bowel syndrome: systematic review and meta-analysis. Psychosom Med. 2014;76(5):389-398. doi:10.1097/PSY.0000000000000039
- Hasan SS, Whorwell PJ, Miller V, et al. Six vs 12 sessions of gut-focused hypnotherapy for irritable bowel syndrome: a randomized trial. Gastroenterology. 2021;160(7):2605-2607.e3. doi:10.1053/j.gastro.2021.02.058
- Palsson OS, Turner MJ, Whitehead WE. Hypnosis home treatment for irritable bowel syndrome: a pilot study. Int J Clin Exp Hypn. 2006;54(1):85-99. doi:10.1080/00207140500328666
- Mind + Gut Clinic. Fees & rebates [Internet]. St Kilda East (VIC): Mind + Gut Clinic; [cited 2026 Sep 24]. mindgutclinic.com.au
- Mindset Health. Nerva: Gut-Brain Program [mobile application]. Apple App Store (Australia); [cited 2026 Sep 24]. apps.apple.com
- Peters SL, Gibson PR, Halmos EP. Smartphone app-delivered gut-directed hypnotherapy improves symptoms of self-reported irritable bowel syndrome: a retrospective evaluation. Neurogastroenterol Motil. 2023;35(4):e14533. doi:10.1111/nmo.14533
- National Cancer Screening Register. Request a free bowel test kit [Internet]. Australian Government; [cited 2026 Sep 24]. ncsr.gov.au
- Australian Government Department of Health, National Bowel Cancer Screening Program; National Cancer Screening Register, 1800 627 701.
Prices and screening eligibility change; both were checked on 18 September 2026.
Related
- Does hypnosis work?The whole evidence base, read in public, including where it fails.
- Do hypnosis apps work?Nerva has real trials behind it. Who paid for them matters.
- All sessionsThe whole catalogue, with prices and running times.
Gut-directed hypnotherapy is the strongest claim my profession has. It is a claim about a course of treatment with a clinician, and I would rather you knew that before you paid me US$18.95 than after.
The session on this page
Every one is an instant MP3 from the publisher at US$18.95, about A$27, with ninety days to change your mind. I earn a commission; it changes neither what you pay nor what I list.
IBS Hypnosis
One recording. Not the six-week protocol the trials tested — read the section above before you buy it.
These are self-help audio sessions, not medical treatment, a diagnosis, or a substitute for professional care. No therapeutic outcome is claimed for any session sold on this site. A recording is not equivalent to a course of clinician-delivered gut-directed hypnotherapy, and nothing here has been evaluated or endorsed by NICE, the British Society of Gastroenterology or the American College of Gastroenterology. IBS should be diagnosed by a doctor, and new or changing bowel symptoms should be investigated before they are managed with anything. Never listen while driving or operating machinery, and do not stop prescribed medication without your doctor’s approval.